Business Description
Fresenius Medical Care AG
NAICS : 621492
SIC : 8092
ISIN : DE0005785802
Share Class Description:
MEX:FME: Ordinary SharesCompare
Compare
Traded in other countries / regions
FME.GermanyFMS.USA0H9X.UK1FME.ItalyFMSC34.BrazilFME.AustriaFME.Mexico IPO Date
2014-10-14Description
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.83 | |||||
| Debt-to-EBITDA | 5.53 | |||||
| Interest Coverage | 3.98 | |||||
| Piotroski F-Score | 9/9 | |||||
| Altman Z-Score | 1.71 | |||||
| Beneish M-Score | -2.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3 | |||||
| 3-Year EBITDA Growth Rate | -8 | |||||
| 3-Year EPS without NRI Growth Rate | -17.1 | |||||
| 3-Year FCF Growth Rate | -15.1 | |||||
| 3-Year Book Growth Rate | 6.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 20.01 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 2.25 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.37 | |||||
| Quick Ratio | 1.02 | |||||
| Cash Ratio | 0.23 | |||||
| Days Inventory | 55.88 | |||||
| Days Sales Outstanding | 70.84 | |||||
| Days Payable | 20.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Payout Ratio | 0.52 | |||||
| 3-Year Dividend Growth Rate | -2.3 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 14.72 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.13 | |||||
| Operating Margin % | 8.65 | |||||
| Net Margin % | 3.43 | |||||
| FCF Margin % | 8.84 | |||||
| ROE % | 4.77 | |||||
| ROA % | 1.93 | |||||
| ROIC % | 3.78 | |||||
| 3-Year ROIIC % | -33.37 | |||||
| ROC (Joel Greenblatt) % | 18.86 | |||||
| ROCE % | 5.87 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.64 | |||||
| Forward PE Ratio | 21.17 | |||||
| PE Ratio without NRI | 17.64 | |||||
| Shiller PE Ratio | 9.5 | |||||
| Price-to-Owner-Earnings | 6.08 | |||||
| PS Ratio | 0.61 | |||||
| PB Ratio | 0.86 | |||||
| Price-to-Free-Cash-Flow | 6.99 | |||||
| Price-to-Operating-Cash-Flow | 5.12 | |||||
| EV-to-EBIT | 13.61 | |||||
| EV-to-EBITDA | 11.01 | |||||
| EV-to-Revenue | 1.16 | |||||
| EV-to-FCF | 13.39 | |||||
| Price-to-Projected-FCF | 0.42 | |||||
| Price-to-Median-PS-Value | 0.5 | |||||
| Earnings Yield (Greenblatt) % | 7.35 | |||||
| FCF Yield % | 14.31 | |||||
| Forward Rate of Return (Yacktman) % | 3.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fresenius Medical Care AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 376,507.472 | ||
| EPS (TTM) (MXN) | 44.785 | ||
| Beta | -0.01 | ||
| Volatility % | 1.36 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (MXN) | 0 | ||
| 20-Day SMA (MXN) | 1591.02 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (MXN) | 1591.02 - 1591.02 | ||
| Shares Outstanding (Mil) | 293.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fresenius Medical Care AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fresenius Medical Care AG Stock Events
| Event | Date | Price(MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Fresenius Medical Care AG Frequently Asked Questions
What is Fresenius Medical Care AG(MEX:FME)'s stock price today?
The current price of MEX:FME is MXN1591.02. The 52 week high of MEX:FME is MXN1591.02 and 52 week low is MXN1591.02.
When is next earnings date of Fresenius Medical Care AG(MEX:FME)?
The next earnings date of Fresenius Medical Care AG(MEX:FME) is 2025-02-20 Est..
Does Fresenius Medical Care AG(MEX:FME) pay dividends? If so, how much?
Fresenius Medical Care AG(MEX:FME) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers